Pegylated interferon plus ribavirin combination therapy in postliver transplant recipients with recurrent hepatitis C virus infection

Pegylated interferon plus ribavirin combination therapy in postliver transplant recipients with recurrent hepatitis C virus infection

Posttransplant hepatitis C virus (HCV) recurrence is universal in chronic hepatitis C recipients. Antiviral therapy is suggested after liver transplant to halt disease progression. Pegylated interferon plus ribavirin therapy remains the standard of care in many areas where direct antiviral agents ar...

Full description

Bibliographic Details
Main Authors: Ta-Ya Lin, Ming-Lun Yeh, Ching-I Huang, Yao-Li Chen, Chia-Yen Dai, Jee-Fu Huang, Zu-Yau Lin, Shinn-Cherng Chen, Chung-Feng Huang, Ming-Lung Yu, Wan-Long Chuang
Format: Article
Language:English
Published: Wiley 2017-06-01
Series:Kaohsiung Journal of Medical Sciences
Subjects:
CHC
HCV
Liver transplantation
Treatment
Online Access:http://www.sciencedirect.com/science/article/pii/S1607551X16303497

Internet

http://www.sciencedirect.com/science/article/pii/S1607551X16303497

Similar Items